Prediction of prolonged air leak after lung resection using continuous log data of flow by digital drainage system.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 27 11 2018
accepted: 11 01 2019
pubmed: 17 4 2019
medline: 16 11 2019
entrez: 17 4 2019
Statut: ppublish

Résumé

The aim of this study was to extract predictive factors of prolonged air leak (PAL) including air flow data as objective parameter by digital drainage system (DDS). The 372 patients who underwent lung resection and had continuous log data of air flow by DDS were reviewed. PAL was defined as the air leak which was exceeding 20 ml/min and lasting 5 days or more. The 69 patients (18.5%) showed air leak and were divided into PAL group (n = 21) and non-PAL group (n = 48). The average flow per hour was calculated at 0, 12, and 24 postoperative hours (POH) and the residual ratio of flow at 12, 24, and 36 POH to that at the time after surgery was analyzed with clinical factors. Area under the receiver-operating characteristic curve (ROC-AUC) was calculated to determine optimal cut-off value of PAL predictors. ROC-AUC for flow at 36 POH was 0.88. Sensitivity and specificity were 0.91 and 0.73 when cut-off value was set at 20 mL/min at 36 POH. ROC-AUC for residual ratio at 36 POH was 0.82. Sensitivity and specificity were 0.81 and 0.79 when cut-off value of residual ratio was set at 0.20. The air flow and the residual ratio measured by DDS will be useful predictors of postoperative PAL after lung resection.

Identifiants

pubmed: 30989584
doi: 10.1007/s11748-019-01073-y
pii: 10.1007/s11748-019-01073-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

684-689

Références

Ann Thorac Surg. 2002 Jun;73(6):1727-30; discussion 1730-1
pubmed: 12078760
J Thorac Cardiovasc Surg. 2003 Mar;125(3):513-25
pubmed: 12658193
Eur J Cardiothorac Surg. 2009 Jan;35(1):28-31
pubmed: 18848460
Ann Thorac Surg. 2010 Jul;90(1):204-9
pubmed: 20609776
Eur J Cardiothorac Surg. 2011 Apr;39(4):584-8
pubmed: 20801054
Eur J Cardiothorac Surg. 2011 May;39(5):e128-32
pubmed: 21316980
Surgeon. 2011 Apr;9(2):72-7
pubmed: 21342670
Interact Cardiovasc Thorac Surg. 2011 Jul;13(1):11-5
pubmed: 21525031
Interact Cardiovasc Thorac Surg. 2011 Nov;13(5):490-3; discussion 493
pubmed: 21852268
Ann Thorac Surg. 2011 Sep;92(3):1062-8; discussion 1068
pubmed: 21871301
Eur J Cardiothorac Surg. 2013 May;43(5):899-904
pubmed: 23024236
Ann Thorac Surg. 2014 Aug;98(2):490-6; discussion 496-7
pubmed: 24906602
Eur J Cardiothorac Surg. 2015 Oct;48(4):608-11
pubmed: 25564213
Ann Thorac Surg. 2016 Sep;102(3):955-961
pubmed: 27234573
Ann Thorac Cardiovasc Surg. 2016 Dec 20;22(6):354-358
pubmed: 27885215
J Thorac Cardiovasc Surg. 2017 Mar;153(3):690-699.e2
pubmed: 27912898
Ann Thorac Surg. 2017 Jul;104(1):275-283
pubmed: 28410638

Auteurs

Masaki Goto (M)

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Keiju Aokage (K)

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan. kaokage@east.ncc.go.jp.

Keigo Sekihara (K)

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Tomohiro Miyoshi (T)

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Kenta Tane (K)

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Kohei Yokoi (K)

Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masahiro Tsuboi (M)

Department of Thoracic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH